OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).

Metadata

Authors/Creators:
  • Merke, D.P.
  • Mallappa, A.
  • Arlt, W.
  • de la Perriere, A.B.
  • Hirschberg, A.L.
  • Juul, A.
  • Newell-Price, J.D.C.
  • Perry, C.G.
  • Prete, A.
  • Rees, A.
  • Reisch, N.
  • Stikkelbroeck, M.
  • Touraine, P.A.
  • Maltby, K.
  • Treasure, P.
  • Porter, J.
  • Ross, R.J.M. ORCID logo https://orcid.org/0000-0001-9222-9678
Copyright, Publisher and Additional Information: © Endocrine Society 2020. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.
Dates:
  • Published (online): 8 May 2020
  • Published: 8 May 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
Diurnal LtdN/A
Depositing User: Symplectic Sheffield
Date Deposited: 22 May 2020 07:31
Last Modified: 22 May 2020 07:31
Status: Published
Publisher: The Endocrine Society
Refereed: Yes
Identification Number: https://doi.org/10.1210/jendso/bvaa046.214

Download

Share / Export

Statistics